Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Rat Ctsk Protein

Cat.No. : Ctsk-441R
Product Overview : Recombinant Rat Ctsk Protein (115-329 aa) without tag was expressed in E. coli.
  • Specification
  • Gene Information
  • Related Products
Description : Cathepsin K, a member of the papain cysteine proteinase family is the predominant proteinase responsible for the resorption of the bone matrix. Cathepsin cleaves proteins such as collagen type I, collagen type II and osteonectin, thereby playing a role in bone remodeling and resorption in osteoporosis, osteolytic bone metastasis and rheumatoid arthritis (Bromme and Okamoto, 1995; Drake, F. et al 1996; Bossard et al, 1996).
Source : E. coli
Species : Rat
Form : Liquid
Molecular Mass : 23.5 kDa
Purity : ≥ 90% (SDS-PAGE)
Storage : Store at −70 centigrade
Concentration : 0.5 mg/mL
Storage Buffer : 0.5 mg/mL solution in 25 mM Na2HPO4 and 500 mM NaCl (pH 7.0) with 50% glycerol.
Shipping : Dry ice
Gene Name : Ctsk cathepsin K [ Rattus norvegicus (Norway rat) ]
Official Symbol : Ctsk
Synonyms : Ctsk; cathepsin K; cathepsin K; EC 3.4.22.38; CTSK; CTSO3; CTSO
Gene ID : 29175
mRNA Refseq : NM_031560
Protein Refseq : NP_113748
UniProt ID : O35186

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (5)

Ask a question
Can CTSK be a target for the development of novel therapeutics for periodontal diseases? 10/10/2022

Yes, CTSK inhibitors are being investigated for their potential in preventing bone loss associated with periodontal diseases.

How does CTSK contribute to the progression of atherosclerosis, and can it be a therapeutic target for cardiovascular diseases? 01/22/2020

CTSK has been linked to vascular calcification in atherosclerosis, and inhibiting its activity may have potential as a therapeutic strategy for cardiovascular diseases.

How might CTSK inhibitors impact the treatment landscape for bone metastasis in cancer patients? 03/26/2018

CTSK inhibitors could potentially be used to limit bone destruction in cancer patients with bone metastasis, improving their quality of life.

Are there any other medical conditions where CTSK inhibitors could be beneficial? 07/29/2017

CTSK inhibitors are being explored for potential therapeutic applications in conditions like rheumatoid arthritis and certain cancers due to their involvement in tissue remodeling.

Are there diagnostic applications for CTSK in identifying bone-related disorders? 11/22/2016

While CTSK is not currently used as a diagnostic marker, its levels and activity could potentially be explored for diagnostic purposes in the future.

Customer Reviews (3)

Write a review
Reviews
09/13/2019

    This guidance can help researchers design and execute their experiments more effectively, ensuring reliable and accurate results.

    01/27/2019

      They have a deep understanding of the CTSK protein and can provide valuable insights into its characteristics, properties, and optimal experimental conditions.

      12/14/2016

        the manufacturer offers outstanding technical support, serving as a valuable resource to resolve any issues that may arise during my research.

        Ask a Question for All Ctsk Products

        Required fields are marked with *

        My Review for All Ctsk Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends